Skip to main content
. 2023 Nov 24;2023:2821056. doi: 10.1155/2023/2821056

Table 3.

Performance of COPD diagnostic questionnaires in study population.

Questionnaire cutoff points Se (CI 95%) Sp (CI 95%) VPP (CI 95%) VPN (CI 95%) LR+ (CI 95%) LR−· (CI 95%) AUC (CI 95%) pvalue
LFQ ≤18 60.1 (56.4–63.8) 19.3 (16.3–22.2) 66.3 (62.7–69.8) 15.5 (12.7–18.2) 1.34 (0.98–1.83) 0.48 (0.35–0.66) 0.66 (0.67–0.71) <0.001
CDQ ≥16 78.6 (75.5–81.7) 47.4 (43.6–51.1) 42.8 (39.0–46.5) 81.6 (78.7–84.S) 1.49 (1.33–1.67) 0.45 (0.40–0.50) 0.68 (0.61−0.73) <0.001
PUMA ≥S 58.8 (55.1–62.5) 64.2 (60.67.8) 38.3 (34.7–42.0) 80.5 (77.5–83.4) 1.64 (1.38–1.94) 0.64 (0.54–0.75) 0.67 (0.62–0.71) <0.001
COULD IT BE COPD ≥3 58.8 (55.1–62.5) 53.2 (49.5–57) 32.3 (28.7–35.8) 77.4 (74.2–80.5) 1.26 (1.08–1.46) 0.77 (0.66–0.90) 0.58 (0.61–0.63) 0.001
COPD-PS ≥4 78.6 (75.5–87.5) 44.3 (33.5–55.2) 34.8 (24.5–45.2) 84.6 (76.7–92.4) 1.41 (1.26–1.57) 0.48 (0.43–0.53) 0.65 (0.66–0.69) <0.001

Se, sensitivity; Sp, specificity; PPV, positive predictive value; NPV, negative predictive value; LR+, positive likelihood ratio; LR−, negative likelihood ratio; AUC, area under the receiver operating characteristic curve.